Novo Nordisk to Acquire Forma Therapeutics for US$1.1 B

By Ashish Tripathi

Pharma Deals Review: Vol 2022 Issue 9 (Table of Contents)

Published: 13 Sep-2022

DOI: 10.3833/pdr.v2022.i9.2721     ISSN: 1756-7874

Section: Mergers & Acquisitions



In a bid to expand its presence in sickle cell disease and rare blood disorders, Novo Nordisk has agreed acquire Forma Therapeutics...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details